Reproducibility study of [18F]FPP(RGD)2 uptake in murine models of human tumor xenografts

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 38, Issue 4, 2011, Pages 722-730

  Chang, Edwin ^a   Liu, Shuangdong ^a   Gowrishankar, Gayatri ^a   Yaghoubi, Shahriar ^a   Wedgeworth, James Patrick ^a   Chin, Frederick ^a   Berndorff, Dietmar ^b   Gekeler, Volker ^b   Gambhir, Sanjiv S ^a,c   Cheng, Zhen ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BAYER PHARMA AG   (Germany)

^c STANFORD UNIVERSITY   (United States)

Author keywords

18F FPP(RGD)2; Angiogenesis; Drug development; Integrins; Reproducibility; Small animal PET scan; Tumor xenograft

Indexed keywords

ARGINYLGLYCYLASPARTIC ACID; FLUORINE 18; PEGYLATED ARGINYLGLYCYLASPARTIC ACID DIMER F 18; UNCLASSIFIED DRUG; VITRONECTIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLON CANCER; DIAGNOSTIC ACCURACY; DRUG UPTAKE; FEMALE; HUMAN; HUMAN CELL; IMAGE ANALYSIS; IMMUNOFLUORESCENCE; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PROTEIN EXPRESSION; REPRODUCIBILITY; TIME; TUMOR VASCULARIZATION; TUMOR VOLUME; TUMOR XENOGRAFT;

ANIMALS; BIOLOGICAL TRANSPORT; CELL TRANSFORMATION, NEOPLASTIC; COLONIC NEOPLASMS; DISEASE MODELS, ANIMAL; FEMALE; HCT116 CELLS; HUMANS; INJECTIONS; MICE; OLIGOPEPTIDES; POLYETHYLENE GLYCOLS; POSITRON-EMISSION TOMOGRAPHY; REPRODUCIBILITY OF RESULTS; TAIL; TUMOR BURDEN; VEINS;

EID: 79953675057     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-010-1672-1     Document Type: Article

References (38)

1. MJ Humphries 2000 Integrin structure Biochem Soc Trans 28 4 311 339 10961914 10.1042/0300-5127:0280311 1:CAS:528:DC%2BD3cXmsVeitb4%3D
2. SK Akiyama 1996 Integrins in cell adhesion and signaling Hum Cell 9 3 181 186 9183647 1:STN:280:DyaK2szis1yhtA%3D%3D
3. R Pasqualini E Koivunen E Ruoslahti 1997 Alpha v integrins as receptors for tumor targeting by circulating ligands Nat Biotechnol 15 6 542 546 9181576 10.1038/nbt0697-542 1:CAS:528:DyaK2sXjslSqsrg%3D (Pubitemid 27251571)
4. JS Desgrosellier LA Barnes DJ Shields M Huang SK Lau N Prévost D Tarin SJ Shattil DA Cheresh 2009 An integrin alpha(v)beta(3)-c-Src oncogenic unit promotes anchorage-independence and tumor progression Nat Med 15 10 1163 1169 19734908 10.1038/nm.2009 1:CAS:528:DC%2BD1MXhtV2gsbvF
5. DG Stupack DA Cheresh 2004 Integrins and angiogenesis Curr Top Dev Biol 64 207 238 15563949 10.1016/S0070-2153(04)64009-9 1:CAS:528:DC%2BD2MXksFyntL8%3D (Pubitemid 39752398)
6. JD Hood R Frausto WB Kiosses MA Schwartz DA Cheresh 2003 Differential alphav integrin-mediated Ras-ERK signaling during two pathways of angiogenesis J Cell Biol 162 5 933 943 12952943 10.1083/jcb.200304105 1:CAS:528: DC%2BD3sXntFeqsbs%3D (Pubitemid 37087732)
7. E Ruoslahti JC Reed 1994 Anchorage dependence, integrins, and apoptosis Cell 77 4 477 478 8187171 10.1016/0092-8674(94)90209-7 1:CAS:528: DyaK2cXltVCrsLo%3D (Pubitemid 24153987)
8. E Ruoslahti 1996 RGD and other recognition sequences for integrins Annu Rev Cell Dev Biol 12 697 715 8970741 10.1146/annurev.cellbio.12.1.697 1:CAS:528:DyaK28XnsFClur0%3D (Pubitemid 26422728)
9. LB Nabors T Mikkelsen SS Rosenfeld F Hochberg NS Akella JD Fisher GA Cloud Y Zhang K Carson SM Wittemer AD Colevas SA Grossman 2007 Phase I and correlative biology study of cilengitide in patients with recurrent malignant glioma J Clin Oncol 25 13 1651 1657 17470857 10.1200/JCO.2006.06.6514 1:CAS:528:DC%2BD2sXlvFyktLY%3D (Pubitemid 46797943)
10. S Maubant D Saint-Dizier M Boutillon F Perron-Sierra PJ Casara JA Hickman GC Tucker E Van Obberghen-Schilling 2006 Blockade of alpha v beta3 and alpha v beta5 integrins by RGD mimetics induces anoikis and not integrin-mediated death in human endothelial cells Blood 108 9 3035 3044 16835373 10.1182/blood-2006-05- 023580 1:CAS:528:DC%2BD28XhtFygtrjK
11. F Perron-Sierra D Saint Dizier M Bertrand A Genton GC Tucker P Casara 2002 Substituted benzocyloheptenes as potent and selective alpha(v) integrin antagonists Bioorg Med Chem Lett 12 22 3291 3296 12392735 10.1016/S0960-894X(02) 00696-0 1:CAS:528:DC%2BD38XotVyrsL0%3D (Pubitemid 35248233)
12. RE Nisato JC Tille A Jonczyk SL Goodman MS Pepper 2003 alphav beta 3 and alphav beta 5 integrin antagonists inhibit angiogenesis in vitro Angiogenesis 6 2 105 119 14739617 10.1023/B:AGEN.0000011801.98187.f2 1:CAS:528: DC%2BD2cXislejtw%3D%3D (Pubitemid 38173862)
13. Y Wu W Cai X Chen 2006 Near-infrared fluorescence imaging of tumor integrin alpha v beta 3 expression with Cy7-labeled RGD multimers Mol Imaging Biol 8 4 226 236 16791749 10.1007/s11307-006-0041-8 (Pubitemid 44193419)
14. AJ Beer M Schwaiger 2008 Imaging of integrin alphavbeta3 expression Cancer Metastasis Rev 27 4 631 644 18523730 10.1007/s10555-008-9158-3 1:CAS:528:DC%2BD1cXhtFCis7zL
15. FA Eskens H Dumez R Hoekstra A Perschl C Brindley S Böttcher W Wynendaele J Drevs J Verweij AT van Oosterom 2003 Phase I and pharmacokinetic study of continuous twice weekly intravenous administration of Cilengitide (EMD 121974), a novel inhibitor of the integrins alphavbeta3 and alphavbeta5 in patients with advanced solid tumours Eur J Cancer 39 7 917 926 12706360 10.1016/S0959-8049(03)00057-1 1:CAS:528:DC%2BD3sXivFCktL0%3D (Pubitemid 36428623)
16. AR Reynolds IR Hart AR Watson JC Welti RG Silva SD Robinson G Da Violante M Gourlaouen M Salih MC Jones DT Jones G Saunders V Kostourou F Perron-Sierra JC Norman GC Tucker KM Hodivala-Dilke 2009 Stimulation of tumor growth and angiogenesis by low concentrations of RGD-mimetic integrin inhibitors Nat Med 15 4 392 400 19305413 10.1038/nm.1941 1:CAS:528:DC%2BD1MXjsVCqtb4%3D
17. M Schottelius B Laufer H Kessler HJ Wester 2009 Ligands for mapping alphavbeta3-integrin expression in vivo Acc Chem Res 42 7 969 980 19489579 10.1021/ar800243b 1:CAS:528:DC%2BD1MXms1Knt78%3D
18. S Liu 2006 Radiolabeled multimeric cyclic RGD peptides as integrin alphavbeta3 targeted radiotracers for tumor imaging Mol Pharm 3 5 472 487 17009846 10.1021/mp060049x 1:CAS:528:DC%2BD28XntVKgtr8%3D (Pubitemid 44639125)
19. R Haubner C Decristoforo 2009 Radiolabelled RGD peptides and peptidomimetics for tumour targeting Front Biosci 14 872 886 19273105 10.2741/3283 1:CAS:528:DC%2BD1MXltFejt7Y%3D
20. AJ Beer M Niemeyer J Carlsen M Sarbia J Nährig P Watzlowik HJ Wester N Harbeck M Schwaiger 2008 Patterns of alphavbeta3 expression in primary and metastatic human breast cancer as shown by 18F-Galacto-RGD PET J Nucl Med 49 2 255 259 18199623 10.2967/jnumed.107.045526 (Pubitemid 351225664)
21. AJ Beer AL Grosu J Carlsen A Kolk M Sarbia I Stangier P Watzlowik HJ Wester R Haubner M Schwaiger 2007 [18F]galacto-RGD positron emission tomography for imaging of alphavbeta3 expression on the neovasculature in patients with squamous cell carcinoma of the head and neck Clin Cancer Res 13 22 Pt 1 6610 6616 18006761 10.1158/1078-0432.CCR-07-0528 1:CAS:528:DC%2BD2sXhtlSmu7nO (Pubitemid 350206795)
22. AJ Beer R Haubner M Sarbia M Goebel S Luderschmidt AL Grosu O Schnell M Niemeyer H Kessler HJ Wester WA Weber M Schwaiger 2006 Positron emission tomography using [18F]Galacto-RGD identifies the level of integrin alpha(v)beta3 expression in man Clin Cancer Res 12 13 3942 3949 16818691 10.1158/1078-0432. CCR-06-0266 1:CAS:528:DC%2BD28XmsValtLk%3D (Pubitemid 44078079)
23. S Liu Z Liu K Chen Y Yan P Watzlowik HJ Wester FT Chin X Chen 2010 18F-labeled galacto and PEGylated RGD dimers for PET imaging of αvβ3 integrin expression Mol Imaging Biol 12 5 530 538 19949981 10.1007/s11307-009- 0284-2
24. Z Wu ZB Li W Cai L He FT Chin F Li X Chen 2007 18F-labeled mini-PEG spacered RGD dimer (18F-FPRGD2): synthesis and microPET imaging of alphavbeta3 integrin expression Eur J Nucl Med Mol Imaging 34 11 1823 1831 17492285 10.1007/s00259-007-0427-0 1:CAS:528:DC%2BD2sXhtFylu7%2FE (Pubitemid 47599045)
25. X Zhang Z Xiong Y Wu W Cai JR Tseng SS Gambhir X Chen 2006 Quantitative PET imaging of tumor integrin alphavbeta3 expression with 18F-FRGD2 J Nucl Med 47 1 113 121 16391195 1:CAS:528:DC%2BD28XhsFeisL4%3D
26. Z Wu ZB Li K Chen W Cai L He FT Chin F Li X Chen 2007 microPET of tumor integrin alphavbeta3 expression using 18F-labeled PEGylated tetrameric RGD peptide (18F-FPRGD4) J Nucl Med 48 9 1536 1544 17704249 10.2967/jnumed.107. 040816 1:CAS:528:DC%2BD2sXhtFGgsLnI (Pubitemid 47397404)
27. Chin FT, Shen B, Liu SL, Berganos RA, Chang E, Mittra E, Chen XY, Gambhir SS. Initial experience with clinical-grade [18F]FPPRGD2: an automated multi-step radiosynthesis for human PET studies. Submitted to Mol Imaging Biol 2010.
28. I Dijkgraaf AJ Beer HJ Wester 2009 Application of RGD-containing peptides as imaging probes for alphavbeta3 expression Front Biosci 14 887 899 19273106 10.2741/3284 1:CAS:528:DC%2BD1MXltFejt7c%3D
29. W Cai J Rao SS Gambhir X Chen 2006 How molecular imaging is speeding up antiangiogenic drug development Mol Cancer Ther 5 11 2624 2633 17121909 10.1158/1535-7163.MCT-06-0395 1:CAS:528:DC%2BD28Xht1els7jE (Pubitemid 44848989)
30. JR Tseng M Dandekar M Subbarayan Z Cheng JM Park S Louie SS Gambhir 2005 Reproducibility of 3'-deoxy-3'-(18)F-fluorothymidine microPET studies in tumor xenografts in mice J Nucl Med 46 11 1851 1857 16269599 1:CAS:528: DC%2BD28XitVGltL0%3D (Pubitemid 46196647)
31. C Knoess S Siegel A Smith D Newport N Richerzhagen A Winkeler A Jacobs RN Goble R Graf K Wienhard WD Heiss 2003 Performance evaluation of the microPET R4 PET scanner for rodents Eur J Nucl Med Mol Imaging 30 5 737 747 12536244 10.1007/s00259-002-1052-6 (Pubitemid 36612958)
32. HM Hudson RS Larkin 1994 Accelerated image reconstruction using ordered subsets of projection data IEEE Trans Med Imaging 13 4 601 609 18218538 10.1109/42.363108 1:STN:280:DC%2BD1c%2FmsFCkuw%3D%3D
33. AM Loening SS Gambhir 2003 AMIDE: a free software tool for multimodality medical image analysis Mol Imaging 2 3 131 137 14649056 10.1162/ 153535003322556877
34. G Atkinson AM Nevill 1998 Statistical methods for assessing measurement error (reliability) in variables relevant to sports medicine Sports Med 26 4 217 238 9820922 10.2165/00007256-199826040-00002 1:STN:280:DyaK1M%2FjvVelsQ%3D%3D (Pubitemid 28505200)
35. M Dandekar JR Tseng SS Gambhir 2007 Reproducibility of 18F-FDG microPET studies in mouse tumor xenografts J Nucl Med 48 4 602 607 17401098 10.2967/jnumed.106.036608 (Pubitemid 47571417)
36. WA Weber SI Ziegler R Thödtmann AR Hanauske M Schwaiger 1999 Reproducibility of metabolic measurements in malignant tumors using FDG PET J Nucl Med 40 11 1771 1777 10565769 1:STN:280:DC%2BD3c%2FivFCquw%3D%3D (Pubitemid 29523568)
37. H Minn KR Zasadny LE Quint RL Wahl 1995 Lung cancer: reproducibility of quantitative measurements for evaluating 2-[F-18]-fluoro-2-deoxy-D-glucose uptake at PET Radiology 196 1 167 173 7784562 1:STN:280:DyaK2MzgsVSiuw%3D%3D
38. AK Iyer G Khaled J Fang H Maeda 2006 Exploiting the enhanced permeability and retention effect for tumor targeting Drug Discov Today 11 17-18 812 818 16935749 10.1016/j.drudis.2006.07.005 1:CAS:528:DC%2BD28XoslOgtLo%3D (Pubitemid 44280021)